While all GRP78-CAR T cell populations had significant anti-AML activity in comparison to control CAR T cells, GRP78.1x-, and GRP78.2x-CAR T cells were more efficacious than GRP78.3x-CAR T cells. Here, HSPA5 is linked to acute myeloid leukemia.